The awareness that chronic kidney disease (CKD) is a condition of dramatically increased cardiovascular risk has prompted an intense research activity, aimed at identifying factors that are specifically involved in the development of cardiovascular complications of CKD and that can be delayed or reduced by novel pharmacological approaches. This...
-
2015 (v1)PublicationUploaded on: April 14, 2023
-
2012 (v1)Publication
Senescence and apoptosis are two distinct cellular programs that are activated in response to a variety of stresses. Low or high doses of the same stressor, i.e., the anticancer drug doxorubicin, may either induce apoptosis or senescence, respectively, in cardiac muscle cells. We have demonstrated that PPARδ, a ligand-activated transcriptional...
Uploaded on: March 31, 2023 -
2021 (v1)Publication
During visceral interventions, the transient clampage of supraceliac aorta causes ischemia/reperfusion (I/R) in kidneys, sometime resulting in acute renal failure; preclinical studies identified redox imbalance as the main driver of I/R injury. However, in humans, the metabolic/inflammatory responses seem to prevail on oxidative stress. We...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
Introduction. Patients with advanced stage of liver disease (ASLD) are often referred for surgical interventions and are at high risk for operative morbidity and mortality. Surgery in the ASLD patients has inherent risks, including bleeding, cytopenias, altered renal perfusion and coagulopathies. Ischemic heart disease (IHD) and structural...
Uploaded on: April 14, 2023